Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase

One of the hallmarks of type 1 but also type 2 diabetes is pancreatic islet inflammation, associated with altered pancreatic islet function and structure, if unresolved. IL-1β is a proinflammatory cytokine which detrimentally affects β-cell function. In the course of diabetes, complement components, including the central complement protein C3, are deregulated. Previously, we reported high C3 expression in human pancreatic islets, with upregulation after IL-1β treatment. In the current investigation, using primary human and rodent material and CRISPR/Cas9 gene-edited β-cells deficient in C3, or producing only cytosolic C3 from a noncanonical in-frame start codon, we report a protective effect of C3 against IL-1β-induced β-cell death, that is attributed to the cytosolic fraction of C3. Further investigation revealed that intracellular C3 alleviates IL-1β-induced β-cell death, by interaction with and inhibition of Fyn-related kinase (FRK), which is involved in the response of β-cells to cytokines. Furthermore, these data were supported by increased β-cell death in vivo in a β-cell-specific C3 knockout mouse. Our data indicate that a functional, cytoprotective association exists between FRK and cytosolic C3.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:121

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 8 vom: 20. Feb., Seite e2312621121

Sprache:

Englisch

Beteiligte Personen:

Kulak, Klaudia [VerfasserIn]
Kuska, Katarzyna [VerfasserIn]
Colineau, Lucie [VerfasserIn]
Mckay, Marina [VerfasserIn]
Maziarz, Karolina [VerfasserIn]
Slaby, Julia [VerfasserIn]
Blom, Anna M [VerfasserIn]
King, Ben C [VerfasserIn]

Links:

Volltext

Themen:

β-cell
C3
Cytokines
Diabetes
FRK
IL-1β
Journal Article

Anmerkungen:

Date Completed 14.02.2024

Date Revised 28.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1073/pnas.2312621121

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368363228